Killing drug-resistant melanoma requires combination therapy
Monday, December 13, 2010 - 17:00
in Health & Medicine
This past summer saw a revolution in melanoma therapy. Patients whose melanoma lesions contain a mutation in the BRAF gene were successfully treated with a BRAF-specific inhibitor, PLX4032. Reports...